In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 17-Valerate, Betamethasone Drug Master File in Korea (17-Valerate, Betamethasone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 17-Valerate, Betamethasone. The MFDS reviews the 17-Valerate, Betamethasone KDMF as part of the drug registration process and uses the information provided in the 17-Valerate, Betamethasone KDMF to evaluate the safety and efficacy of the drug.
After submitting a 17-Valerate, Betamethasone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 17-Valerate, Betamethasone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 17-Valerate, Betamethasone suppliers with KDMF on PharmaCompass.